David C. Ott, 10% Owner at Zentalis Pharmaceuticals, Inc. (ZNTL), bought 725,000 shares at $18.00 ($13.1M) on 2020-04-07, disclosed to the SEC on 2020-04-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| ROIV | SELL | 2023-06-26 | $257.4M | — | Filing → |
| FLAC | BUY | 2022-11-04 | $17.1M | — | Filing → |
| INBX | BUY | 2022-10-12 | $40.0M | — | Filing → |